basic method used by everyone. Methods of personal choice would be additional and would serve to improve the basic method from time to time as experience is gained and different needs arise.
Summary
The problem of primary isolation of bacteria from patients is discussed.
Blood agar, MacConkey agar and media for the isolation of intestinal pathogens made by different manufacturers and prepared in different laboratories were tested in parallel. Grea1t variations in performance were demonstrated.
Recommendations are made for better standardization of methods and 'in use' control of media so that computer analysis of results will be meaningful. Carnot & Deflandre (1906) postulated the existence of a hormonal regulating mechanism for erythropoiesis. In 1957 Jacobsen et al. localized the site of production of this hormone, erythropoietin, in the kidneys. A number of attempts have been made to assay tumours associated with polycythxemia for their erythropoietin content, and to show that they exert their effect by the erythropoietin they contain.
Assays of erythropoietin activity of tumour, plasma or urine have been reported in 21 patients. In only one of these studies (Shalet et al. 1967) was the activity of a Wilms' tumour related to a standard erythropoietin in a satisfactory assay. The tumour was active but no studies were done on the plasma or urine. In order to prove that erythropoietin is concerned in these unusual cases it is necessary to show erythropoietin activity in the tumour and increased amounts in the plasma and urine. These assays should be related to an erythropoietin standard. Proof that erythropoietin secretion is the mechanism in every case is not convincing and one must agree with Penington (1961) that 'still more definitive studies will be required in such subjects before the significance of these clinical associations can be assessed'.
The secretion of erythropoietin may be decreased in some malignant conditions, notably leukaemia. In 1965 Thorling, studying acute and chronic leukxemias, found that although a reciprocal relationship existed between anemia and erythropoietin levels in most cases, on occasion anamic chronic myeloid leukaemic patients did not show a rise in erythropoietic activity. These sera were assayed without the use of an erythropoietin standard.
A preliminary study has been made of 12 patients with various types of leuk2emia using a hypoxic polycythemic mouse assay (Cotes & Bangham 1961) , and an erythropoietin standard in a four-point assay (Gordon et al. 1964 ). All the patients with acute leukemia who became anemic responded by producing erythropoietin.
Some patients with chronic myeloid leukwmia and chronic lymphatic leukemia did not do this. The cause is not obvious but it would seem from this preliminary study that patients with chronic myeloid leukaemia who fail to produce erythropoietin have a poor prognosis.
The Effect ofHodgkin's Disease on Immunoglobulin Levels
The immunological aspects of Hodgkin's disease have been of considerable interest. Recently, Crowther et al. (1967) have identified large lymphoid cells present in the plasma of patients with untreated Hodgkin's disease, and have shown an increased DNA synthesis in peripheral blood lymphoid cells. One possible explanation for this finding is that an immunological reaction was in progress. It was of interest, therefore, to study the patients' immunoglobulin levels.
Sixty-four patients with Hodgkin's disease confirmed by histology of lymph-node biopsy were studied. The immunoglobulins were estimated by a modified Mancini method (Mancini et al. 1965) using radial immunodiffusion in agar. A normal range -was established for yM of 45-195 mg/100 ml. Twenty-nine of the sera or 45 % showed low levels of yM. Levels of yG and yA were relatively normal.
The level of yM was then correlated with the patient's age, duration of disease, stage of illness, and severity of disease. The survival time after the sample was taken was the criterion for the measurement of severity of disease. The relationship to therapy and of yM levels to total white cell count, polymorph, lymphocyte and monocyte counts was examined. A multiple regression analysis was done using a computer.
The only significant correlation was the level of yM and the total lymphocyte count in patients in the late stage of Hodgkin's disease. The lymphocyte count and the yM levels were directly related. A positive regression coefficient of 078 was obtained.
The cause of the low level of yM is difficult to ascertain. It would be expected that treatment might depress the cells of the reticuloendothelial system responsible for producing yM. Nevertheless, a total of 10 patients with low yM levels had received no therapy when the sample was taken. It may be significant that all of the untreated patients with low yM levels were in the later stages of the disease. This may be explained by the lymphoid depletion that can occur in the later stages of Hodgkin's disease. The decrease in yM levels as the lymphocyte count falls is further evidence of this. Goldman & Hobbs (1967) also found a tendency to decreased yM levels in late Hodgkin's disease and demonstrated that this was not due to radiotherapy or chemotherapy.
At the present time it is not possible to give a reason for this profound effect on yM levels in disease of the reticuloendothelial system. It is possible that it may provide a clue to the letiology of these diseases.
Dr Suzanne Alexander
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The Effects of Carcinoma on the Skin Skin changes accompanying internal carcinoma and other malignant conditions have been noted for more than a hundred years. Sometimes these associated skin changes may precede the diagnosis of the carcinoma and sometimes they may actually precede the occurrence of the malignancy.
As early as 1868 Hebra commented on the cachexia and pigmentation of the skin in a patient with advanced carcinoma. Since then a variety of skin changes have been described in patients with malignant disease, and some of these changes are so constantly observed in association with certain types of new growth that they may serve as 'markers of malignancy' (Sneddon 1963) . Some conditions such as pruritus or urticaria occur so commonly that their presence alone cannot be taken as sufficient ground for instituting a search for carcinoma.
In certain families a particular genetic abnormality, such as polyposis of the colon, may be associated with subcutaneous bony tumours of the maxilla, mandible and cranial bones (Plenk & Gardner 1954) . Polyposis of the gastrointestinal tract may be associated with pigmentation of the lips and mucous membranes as in Peutz-Jeghers syndrome (Peutz 1921, Jeghers et al. 1949).
